Full Breakdown
U.S. Senators Urge Action on Bird Flu Vaccine Development
12/11/2025, 9:06:23 PM
Urgent Call for Vaccine Development
A bipartisan group of 23 U.S. senators has called on the administration of President Donald Trump to expedite the development of a science-based plan for a bird flu vaccine aimed at livestock. This request follows a significant outbreak of bird flu that has resulted in the culling of over 180 million chickens, turkeys, and other poultry since 2022. The senators, led by Amy Klobuchar (D-MN) and Mike Rounds (R-SD), emphasized the need for the U.S. Department of Agriculture (USDA) to take "renewed action" as infections are expected to rise during the winter months.
Background on Bird Flu Impact
The bird flu outbreak has had severe repercussions for the poultry industry, including skyrocketing egg prices. In response, the USDA announced in March that it would allocate $100 million for research into vaccines and therapeutics specifically for egg-laying chickens. However, despite receiving 417 proposals for funding, the USDA has not provided further details on the vaccination strategy.
Concerns Over Trade Implications
The senators' letter to Agriculture Secretary Brooke Rollins highlighted the importance of incorporating feedback from animal health stakeholders and industry experts into any finalized vaccine strategy. They also urged the USDA to collaborate with trading partners and affected producers to evaluate and manage potential trade implications that could arise from implementing a vaccination plan. The poultry industry remains divided on the issue, with concerns that vaccination could negatively impact exports.
Official Statements & Responses
In their correspondence, the senators stressed that any vaccine strategy must be grounded in sound science. They noted the USDA's previous commitment to developing a poultry vaccination plan but expressed frustration over the lack of updates since June. The USDA has not yet shared a vaccination plan with international trading partners, raising concerns about the potential impact on trade relations.
Criticism & Opposition
The situation is further complicated by the Trump administration's decision in May to cancel a $700 million contract with Moderna for the development of a human bird flu vaccine. Additionally, Health Secretary Robert F. Kennedy Jr. has been criticized for cutting funding for vaccine research and dismantling long-standing federal vaccine guidelines, which may hinder efforts to combat the bird flu effectively.
What's Next
As the winter months approach, the urgency for a comprehensive bird flu vaccination strategy intensifies. The USDA's next steps in developing and communicating a plan will be closely monitored by both industry stakeholders and lawmakers, as the implications of the ongoing outbreak continue to unfold.
Verbatim Quotes
“Any finalized vaccine strategy must take into account ?feedback from animal health ?stakeholders, industry experts, and be grounded in sound science,” — Amy Klobuchar, U.S. Senator
